Summary
Radical prostatectomy has been the mainstay of treatment for localized prostate cancer for over 50 years, but its value has been controversial. This report evaluates the impact of this therapeutic modality by assessing the value of various prognostic stratification systems in predicting the clinical outcome. Traditional stratifiers such as clinical stage, pathologic stage, and tumor grade are reviewed, as well as newer biologic parameters such as DNA content determined by automated flow cytometric analysis. Such newer predictors of response may enable an approach of selective enhanced aggressiveness in treating regional, advanced disease.
Similar content being viewed by others
References
Barzell W, Bean MA, Hilaris BS, Whitmore WF Jr (1977) Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases. J Urol 118:278–282
Byar DP, Mostofi FK (1972) Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies examined by the step-section technique. Cancer 30:5–13
Cifone M, Fidler IJ (1981) Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci UA 78:6949–6952
Donahue RE, Mani JH, Whitesel JA, Mohr S, Scanavino D, Augspurger RR, Biber RJ, Fauver HE, Wettlaufer JN, Pfister RR (1982) Pelvic lymph node dissection: guide to patient management in clinically locally confined adenocarcinoma of prostate. Urology 20:559–565
Elder JS, Jewett HJ, Walsh PC (1982) Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate. J Urol 127:704–706
Fordham MVP, Burdge AH, Matthews J, Williams G, Cooke T (1986) Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome. Br J Surg 73:400–403
Frankfurt OS, Chin JL, Englander LS, Greco WR, Pontes JE, Rustum YM (1985) Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer. Cancer Res 45:1418–1423
Friedlander ML, Hedley DW, Taylor IW (1984) Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol 37:961–974
Gibbons RP, Correa RJ Jr, Brannen GE, Mason JT (1984) Total prostatectomy for localized prostate cancer. J Urol 131:73–76
Gleason DF (1966) Classification of prostatic carcinomas. Cancer Chemother Rep 50:125–128
Gleason DF, Mellinger GT (1974) The Veterans Administration Cooperative Urological Research Group: prediction of prognosis for prostatic adenocarinoma by combined histological grading and clinical staging. J Urol 111:58–64
Grossman HB, Batata H, Hilaris B, Whitmore WF Jr (1982) 125-I implantation for carcinoma of the prostate: further followup of the first 100 cases. Urology 20:591–598
Gutierrez R (1949) New horizons in surgical management of carcinoma of prostate gland. Am J Surg 78:147–169
Hart IR, Fidler IJ (1981) The implications of tumor heterogeneity for studies on the biology and therapy of cancer metastasis. Biochim Biophys Acta 651:37–50
Jewett HJ (1954) Radical perineal prostatectomy for carcinoma. An analysis of cases at Johns Hopkins Hospital, 1905–1954. JAMA 156:1039–1041
Jewett HJ, Bridge RW, Gray GF Jr, Shelley WM (1968) The palpable nodule of prostatic cancer: results 15 years after radical excision. JAMA 203:403–406
Jewett HJ, Eggleston JC, Yawn DH (1972) Radical prostatectomy in the management of carcinoma of the prostate: probable causes of some therapeutic failures. J Urol 107:1034–1040
Kramer SA, Spahr J, Brendler CB, Glenn JF, Paulson DF (1980) Experience with Gleason's histopathologic grading in prostatic cancer. J Urol 124:223–225
Kramer SA, Cline WA Jr, Farnham R, Carson CC, Cox EB, Hinshaw W, Paulson DF (1981) Prognosis of patients with stage D1 prostatic adenocarcinoma. J Urol 125:817–819
Lee SE, Currin SM, Paulson DF, Walther PJ (1988) Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence. J Urol 140:769–774
McCullough DL, Leadbetter WF (1972) Radical pelvic surgery for locally extensive carcinoma of the prostate. J Urol 108:939–943
Middleton RG, Smith JA Jr, Melzer RB, Hamilton PE (1986) Patient survival and local recurrence rate following radical prostatectomy for prostatic carcinoma. J Urol 136:422–424
Mostofi FK (1975) Grading of prostatic carcinoma. Cancer Chemother Rep 59:111–117
Mukamel E, DeKernion JB, Hannah J, Smith RB, Skinner DG, Goodwin WE (1987) The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate. Cancer 59:1535–1538
Oesterling JE, Epstein JI, Walsh PC (1987) Long-term autopsy findings following radical prostatectomy. Urology 29:584–588
Paulson DF (1980) The prognostic role of lymphadenectomy in adenocarcinoma of the prostate. Urol Clin North Am 7:615–622
Paulson DF, Stone AR, Walther PJ, Tucker JA, Cox EB (1986) Radical prostatectomy: anatomical predictors of success or failure. J Urol 136:1041–1043
Sagalowsky AI, Milam H, Reveley LR, Silva FG (1982) Prediction of lymphatic metastases by Gleason histologic grading in prostatic cancer. J Urol 128:951–952
Schellhammer PF (1988) Radical prostatectomy. Patterns of local failure and survival in 67 patients. Urology 31:191–197
Smith JA Jr, Seaman JP, Gleidman JB, Middleton RG (1983) Pelvic lymph node metastasis from prostatic cancer: influence of tumor grade and stage in 452 consecutive patients. J Urol 130:290–292
Stephenson RA, James BC, Gay H, Fair WR, Whitmore WF Jr, Melamed MR (1987) Flow cytometry of prostate cancer: relationship of DNA content to survival. Cancer Res 47:2504–2509
Tavares A, Costa J, Maia J (1973) Correlation between ploidy and prognosis in prostatic carcinoma. J Urol 109:676–679
Turner RD, Belt E (1957) A study of 229 consecutive cases of total perineal prostatectomy for cancer of the prostate. J Urol 77:62–77
Walsh PC, Lepor H (1987) The role of radical prostatectomy in the management of prostatic cancer. Cancer 60:526–537
Westerborn A (1950) Radical treatment of cancer of the prostate by cystovesiculoprostatectomy. Surg Gynecol Obstet 91:751–756
Whitmore WF Jr, Mackenzie AR (1959) Experience with various operative procedures for the total excision of prostatic cancer. Cancer 12:396–405
Winkler HZ, Rainwater LM, Myers RP, Farrow GM, Therneau TM, Zincke H, Lieber MM (1988) Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry. Mayo Clinic Proc 63:103–112
Zetterberg A, Exposti PL (1980) Prognostic significance of nuclear DNA levels in prostatic carcinoma. Scand J Urol Nephrol [Suppl] 55:53–58
Zincke H, Utz DC (1984) Observations on surgical management of carcinoma of prostate with limited nodal metastases. Urology 24:137–145
Zincke H, Farrow GM, Myers RP, Benson RC Jr, Furlow WL, Utz DC (1982) Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases. J Urol 128:498–501
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Walther, P.J. The role of radical prostatectomy in the management of prostatic adenocarcinoma. World J Urol 7, 38–44 (1989). https://doi.org/10.1007/BF01576843
Issue Date:
DOI: https://doi.org/10.1007/BF01576843